Publikationen

King, V.J.; Nussbaumer-Streit, B.; Shaw, E.; Devane, D.; Kahwati, L.; Viswanathan, M.; Gartlehner, G.; Cochrane Rapid Reviews Methods Group (2024). Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews. BMJ Evidence-Based Medicine, 29: 419-422

Griebler, U.; Kien, C.; Klerings, I.; Lutz, B.; Krczal, E.; Ledinger, D.; Mair, I.; Emprechtinger, R.; Keser Aschenberger, F.; Kerschner, B. (2024). Info without Side Effects (iWISE): Development of a validated lay checklist for assessing online health information - a mixed-methods study. JMIR Preprints, preprint: 10.2196/preprints.69529

GBD 2021 HIV Collaborators; Sharifan, A. (2024). Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV, 11, Issue 12: e807-e822

Emprechtinger, R.; Schwarzer, G.; Schreder, G.; Tolch, U.; Gartlehner, G. (2024). Assessing the Effectiveness of metaHelper: A Randomized Controlled Trial of a Web Application for Statistical Transformations in Meta-Analysis. Journal of Clinical Epidemiology, online ahead of print: https:// doi.org/10.1016/j.jclinepi.2024.111640

GBD 2021 US Obesity Forecasting Collaborators; Sharifan, A. (2024). Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet, 404: 2341-70

GBD 2021 US Obesity Forecasting Collaborators; Sharifan, A. (2024). National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet, 404: 2278-98

Crotty, K.; Gartlehner, G; Viswanathan, M. (2024). Response to Commentary by Mattos et al. (2024). J Consult Clin Psychol, 92, Issue 11: 782-783

Sharifan, A. (2024). Analysis of Cochrane systematic reviews: A comprehensive study of impact and influence from 1998 to 2024. Cochrane Evidence Synthesis and Methods, 2:12: 1-12

Sharifan, A. (2024). Melatonin and erectile dysfunction: addressing research gaps and proposing future investigations. International Journal of Impotence Research, published online: https://doi.org/10.1038/s41443-024-01002-5

GBD 2021 Tobacco Forecasting Collaborators; Sharifan, A. (2024). Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, Volume 9, Issue 10,: e729 - e744

GBD 2021 Stroke Risk Factor Collaborators; Sharifan, A. (2024). Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology, Volume 23, Issue 10: 973 - 1003

Affengruber, L.; Van der Maten, M.M.; Spiero, I.; Nussbaumer-Streit, B.; Mahmic-Kaknjo, M.; Ellen, M.E.; Goossen, K.; Kantorova, L.; Hooft, L.; Riva, N.; Poulentzas, G.; Lalagkas, P.N.; Silva, A.G.; Sassano, M.; Sfetcu, R.; Marqués, M.E.; Friessova, T.; Baladia, E.; Pezzullo, A.M.; Martinez, P.; Gartlehner, G.; Spijker, R. (2024). An exploration of available methods and tools to improve the efficiency of systematic review production: a scoping review. BMC Medical Research Methodology, 24, 210: https://doi.org/10.1186/s12874-024-02320-4

Moser, I.; Sommer, I.; Gartlehner, G. (2024). WHO-Leitlinie zur nicht-operativen Behandlung chronisch unspezifischer Kreuzschmerzen bei Erwachsenen in der Primärversorgung. Das Gesundheitswesen, Online ahead of print.: doi: 10.1055/a-2375-3671.

Devane, D.; Hamel, C.; Gartlehner, G.; Nussbaumer-Streit, B.; Griebler, U.; Affengruber, L.; Saif-Ur-Rahman, K.M.; Garritty, C. (2024). Key concepts in rapid reviews: an overview. Journal of Clinical Epidemiology, 175: 1-5

Sharifan, A.; Sivaprasad, S. (2024). Exploring the unexplored: identifying knowledge gaps in novel pharmacological treatments for diabetic retinopathy. Eye, https://doi.org/10.1038/s41433-024-03349-x: https://doi.org/10.1038/s41433-024-03349-x

GBD 2021 Antimicrobial Resistance Collaborators; Sharifan, A. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet, Volume 404, Issue 10459: p1199-1226

Mathes, T.; Prien, P.; Klerings, I.; Ewald, H.; Dressler, C.; Harder, T.; Scheibler, F.; Büchter, R.; Braun, C.; Grummich, K.; Eikermann, M.; Schaefer, C.; Pieper, D. (2024). Guidance on how to efficiently find, choose, and use available systematic reviews was developed. Journal of Clinical Epidemiology, 173: https://doi.org/10.1016/j.jclinepi.2024.111466

Sharifan, A. (2024). Comment on “Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis”. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 20, 1: https://doi.org/10.1080/21645515.2024.2404290

Sommer, I.; Nußbaumer-Streit, B.; Gartlehner, G. (2024). WHO-Leitlinie zur Kohlenhydratzufuhr für Erwachsene und Kinder. Das Gesundheitswesen, 8/9: 2364-2388

Hoekstra, D.; Mütsch, M.; Borchard, A.; Kien, C.; Griebler, U.; Von Elm, E.; Rehfuess, E.; Gerhardus, A.; Lhachimi, S.K. (2024). A Structured Approach to Involve Stakeholders in Prioritising Topics for Systematic Reviews in Public Health. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 69: 1-11